Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Longfa Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company specializing in the cultivation, research, development, manufacturing, and marketing of traditional Chinese medicine (TCM), ethnic Yi medicine, and chemical pharmaceuticals. Established originally in 1967 as Chuxiong Pharmaceutical Factory and acquired by Hong Kong Long Far Pharmaceutical Group in 2003, the company is recognized as a key ethnic medicine manufacturer in Yunnan Province. Its extensive product portfolio includes over 180 approved drug products, with notable brands such as Qiuxieling Mixture, Chenxiang Lu Bailu Tablets, Vitamin C Yinqiao Tablets, and Bushen Banlong Tablets. Yunnan Longfa Pharmaceutical operates modern GMP-certified manufacturing facilities capable of producing multiple dosage forms, including capsules, tablets, granules, and oral liquids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Longfa Pharmaceutical.